Recent performance snapshot for Integer Holdings

Integer Holdings (ITGR) has been on the radar after a strong single day move, with the stock up about 5.2%, adding to gains of roughly 3.6% over the past week.

Over the past month the stock is up about 1.9%, and over the past 3 months it has gained roughly 4.7%, compared with a year total return that is down about 25.3%.

The latest 5.2% one day share price return builds on shorter term momentum, yet it sits against a weaker backdrop, with the 1 year total shareholder return down 25.3% and the 5 year total shareholder return slightly negative.

If this kind of move has you looking around the market, it could be a good time to scan for other ideas using the Simply Wall St screener focused on 33 healthcare AI stocks

With Integer Holdings showing a recent share price rebound but a 1-year total return still down 25.3%, does the current valuation suggest an undervalued medical device manufacturer, or is the market already factoring in potential future growth?

Most Popular Narrative: 5.9% Undervalued

Integer Holdings last closed at $89.39, compared with a widely followed fair value narrative of $95, which frames the current valuation debate around modest upside potential.

Ongoing investments in manufacturing automation and operational excellence initiatives are yielding sequential gross and operating margin improvements, with expectations for further quarterly expansion through the year, underpinning continued net margin and earnings growth. Enhanced strategic partnerships and long-term contracts with leading OEMs, covering approximately 70% of business, provide stable, visible demand and improved pricing power, supporting consistent earnings and reducing revenue volatility.

Curious what kind of revenue pace, margin profile and future earnings multiple are baked into that $95 fair value? The narrative leans on measured growth assumptions, a specific profitability path and a valuation multiple that sits below the broader medical equipment peer group, all stitched together using an 8.5% discount rate.

Result: Fair Value of $95 (UNDERVALUED)

However, there is still a real risk that concentrated OEM exposure and underperforming products, including the neuromodulation program and portable medical exit, may undercut this fair value story.

Next Steps

This mix of optimism and caution around Integer Holdings is clear, so move quickly to review the data, weigh both sides, and check out the 4 key rewards and 1 important warning sign.

Ready to hunt for more opportunities?

Do not stop with a single stock. Use the tools at hand, compare ideas, and keep building a watchlist that truly fits your goals and risk comfort.

• Target stability with companies that pass strict balance sheet and fundamentals checks through the solid balance sheet and fundamentals stocks screener (45 results).
• Spot potential value candidates by scanning the 47 high quality undervalued stocks before others catch on.
• Unearth lesser known businesses with strong fundamentals using the screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.